Compounded Lyophilized AOD-9604 Injection Recalled for Sterility Risk
Innoveix Pharmaceuticals is recalling compounded lyophilized AOD-9604 3 mg injection vials nationwide due to lack of assurance of sterility. The affected product was distributed as Rx-only injectable medication.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a compounded injectable drug with a sterility assurance failure, which poses a direct risk of serious infection if contaminated product was administered. Class II recalls with risk of serious health consequences map to Severe (score 4) per the rubric.
Plain-English summary
Innoveix Pharmaceuticals Inc is recalling 1,316 vials of compounded lyophilized AOD-9604, 3 mg, for subcutaneous or intramuscular injection nationwide. The recall is due to lack of assurance of sterility.
The affected product was compounded by Innoveix in Addison, TX and distributed for use as an Rx-only injectable medication. Four lots are affected: AOD205 (expiration 11/09/2021), AOD210 (expiration 11/18/2021), AOD215 (expiration 12/15/2021), and AOD220 (expiration 01/20/2022).
Consumers who have received this product should consult their healthcare provider. The FDA classifies this as a Class II recall.
The recalled product
- Product
- Compounded Lyophilized AOD-9604, 3 mg For subcutaneous or intramuscular injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
- Manufacturer
- Innoveix Pharmaceuticals Inc
- Category
- Drug — Compounded Injectable
- Affected units
- 1,316
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: AOD205 Exp. 11/09/2021
- AOD210 Exp. 11/18/2021
- AOD215 Exp. 12/15/2021
- AOD220 Exp. 01/20/2022.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Innoveix Pharmaceuticals Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Innoveix Pharmaceuticals Inc
See all →- SevereCompounded Semorelin/Ipamorelin Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-07-28
- SevereInnoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Human Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
- SevereInnoveix Recalls Lyophilized Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-06
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15